Literature DB >> 7363935

Quantitation of CSF concentrations and biological activity of probenecid metabolites.

B E Roos, G Wickström, P Hartvig, J L Nilsson.   

Abstract

The concentrations of probenecid and four of its metabolites have been examined in plasma and CSF by electron capture gas chromatography after extractive methylation. The plasma concentration of each of the metabolites was in the range 1,5-15 micrograms/ml and constituted less than 10% of the parent compound. The penetration into CSF of the metabolites was lower than that of probenecid. The concentration of each of the metabolites was below 0,2 microgram/ml and the total concentration never exceeded 10% of the probenecid concentration. The inhibitory effect of the metabolites on uptake was tested in rabbit renal cortex using 3H-p-amino-hippuric acid. The inhibitory effect was low. From the low activity and relatively low concentrations of the metabolites do not contribute to the probenecid-induced blocking effect of acid transport from the CSF.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7363935     DOI: 10.1007/bf00561904

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Dose-dependence of drug plasma level decline in dogs.

Authors:  P G Dayton; S A Cucinell; M Weiss; J M Perel
Journal:  J Pharmacol Exp Ther       Date:  1967-11       Impact factor: 4.030

2.  Selectivity of probenecid congeners for different organic acid transport systrms in rabbit renal cortex.

Authors:  E H Bárány
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-10

3.  Metabolites of probenecid. Chemical, physical, and pharmacological studies.

Authors:  Z H Israili; J M Percel; R F Cunningham; P G Dayton; T F Yü; A B Gutman; K R Long; R C Long; J H Goldstein
Journal:  J Med Chem       Date:  1972-07       Impact factor: 7.446

4.  Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.

Authors:  R Olsson; B E Roos
Journal:  Nature       Date:  1968-08-03       Impact factor: 49.962

5.  5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid.

Authors:  H M van Praag; J Korf; J Puite
Journal:  Nature       Date:  1970-03-28       Impact factor: 49.962

6.  Identification and renal excretion of probenecid metabolites in man.

Authors:  J M Perel; R F Cunningham; H M Fales; P G Dayton
Journal:  Life Sci I       Date:  1970-12-01

7.  Electron-capture gas chromatography of sulphapyridine and its N4-acetyl metabolite in serum after extraction methylation.

Authors:  O Glyllenhaal; B Näslund; P Hartvig
Journal:  J Chromatogr       Date:  1978-09-11

8.  Studies of the fate of metabolites and analogs of probenecid. The significance of metabolic sites, especially lack of ring hydroxylation.

Authors:  P G Dayton; J M Perel; R F Cunningham; Z H Israili; I M Weiner
Journal:  Drug Metab Dispos       Date:  1973 Nov-Dec       Impact factor: 3.922

9.  Inhibition by hippurate and probenecid of in vitro uptake of iodipamide and o-iodohippurate. A composite uptake system for iodipamide in choroid plexus, kidney cortex and anterior uvea of several species.

Authors:  E H Bárány
Journal:  Acta Physiol Scand       Date:  1972-09
  9 in total
  3 in total

1.  Changes in extracellular acid-base homeostasis in cerebral ischemia.

Authors:  D L Taylor; T P Obrenovitch; L Symon
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

2.  Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans.

Authors:  T B Vree; E W Beneken Kolmer
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

3.  Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study.

Authors:  T B Vree; E W Van Ewijk-Beneken Kolmer; E W Wuis; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1992-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.